The University of Chicago Header Logo

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma. Blood Adv. 2025 Sep 23; 9(18):4687-4692.

View in: PubMed